| The members | of the Board who | served as agents for the Corporate Trustee during |
the | financial | year were |
|---|---|---|---|---|---|
| correctly diedosed as fogows: | |||||
| Derek Bell | Joint Chairman | ||||
| Jugs Ann Gilfon | Chief Executive to31st March 2D23 | ||||
| Anandapuram | Deepak Dwarakanath | Chief Medical Officer to21stSeptember 2023 /Deputy | Chief Executive to | ||
| 30th September 2023 | |||||
| Elaine Gook | Interim Chief Medical Officer from 22nd September | 2023 | |||
| Alan Sheppard | Chief People Officer to 31stAugust 2022 | ||||
| Neil Atkinson | Managing Director from 1st April 2023 |
||||
| Graham Evans |
Chief Information Technology Officer to31st May 2022 |
||||
| Levl Bucklay | Chief Operating Officer to 3Dth Apdf 2023 |
||||
| Stephen Hall |
Vice Chairman and hfon-executive Director to 31st |
March 2023 | |||
| Ann Baxter | Vice Chair from 1 April 2023 | ||||
| Lfndsey Robertson | Chief Nuse/Director of Patient Safety end Quality |
||||
| Linda Hunter | Director of Planning &Performance |
||||
| Graham Walton |
Non-executive Director to 17th March 2023 |
||||
| Christopher Macklin |
Non-executive Director |
||||
| Gglian Colquhoun | Chief Informsffon 8 Technology Offfcer from 30th May 2022 to 30th June |
||||
| 2023 | |||||
| Ken Anderson | Chief fnformation 8 Technology Offfcer from 30th October 2023 |
||||
| Suey Cook | Chief People Office/Director ofCorporate Affairs |
||||
| Fey Scugion | Norvexacutlve Director |
||||
| lsn Simpson | Chair of NTH Solutions LLP and Optimus Limited Company (Non- |
||||
| Execulive Director) | |||||
| James Bromiley | Norvexecutive Director from 1st February 2023to 31stJuly 2023 |
||||
| Algeon Fellows | Non-executive Director |
||||
| Elizabeth Bames | Non-executive Direrlor fmm 1st February 2023 |
||||
| Kate Hudson-Hslliday | Acting Director of Finance from 1stJune 2023 | ||||
| Rowena Dean | Acting Chief Operating ONcer from 24th April 2023 |
||||
| Michaef Houghton | Director ofTransformation from 1Dth July 2023 |
||||
| Stuart Iivlne | Director ofStrategy, Assurance &Compliance from |
1Dlh July 2023 |
| m | E | ||||
|---|---|---|---|---|---|
| Paxman cooling ceps to prevent |
hair loss during chemotherapy | treatment | 34 | ||
| Anetic aid patient trolley stroke | unit | 7 | |||
| Vien viewer flex Hasmatology | 5 | ||||
| Benevision N1 Monitor Stroke unit |
5 | ||||
| Other medical eqvipmenl | |||||
| 57 |
| ajor refurbishm | ents and ITequipment purchases during Ihe y |
ear are shown b | elow: | |
|---|---|---|---|---|
| ~Edll | rra | |||
| Touchscreen | devices, trolley and software used by dementia | patients | ||
| Refurbishment | urology room | |||
| Other refurbishment costs |
||||
| 15 |
| Staff | training | 67 |
|---|---|---|
| Other | staff welfare | 30 |
| 97 |
| Staff lottery | winnings paid |
29 | |
|---|---|---|---|
| Statf lottery | administration | costs | 1 |
| Fundralsing | Events costs | 18 | |
| Fundraising | salary recharge costs | 42 | |
| 90 |
| Funds managed | by CCLA | For Charities are | as follows: | |
|---|---|---|---|---|
| Equities | f000 | |||
| COIF Charities | Investment | Fund | 1,414 | 100 |
| Total | 1,414 | 100 |
| Total | Total | |||||||
|---|---|---|---|---|---|---|---|---|
| Note | Unreslrided | Restricted | Funds | Funds | ||||
| Funds | Funds | 2022/23 | 2021/22 | |||||
| 8000 | 8000 | 8000 | EDOO | |||||
| Income and endowments | from: | |||||||
| Donations | 3 | 458 | 110 | 568 | 498 | |||
| Legacies | 3 | 'I61 | ||||||
| Charitable activities |
4 | 3'I | 3'I | 41 | ||||
| Other trading activities-Fundraising |
Events- Staff lottery | 5 | 5 | 43 | 48 | 43 | ||
| Other incoming resources |
6 | 6 | 9 | 15 | 5 | |||
| Investment Income |
13.3 | 23 | 18 | 41 | 41 | |||
| Total incoming resources |
492 | 211 | 703 | 789 | ||||
| Expenditure on: |
||||||||
| Raising Funds | 60 | 30 | 90 | 55 | ||||
| Charitable activities: |
||||||||
| Research Posts and Clinical | Care | 37 | 37 | 4 | ||||
| Pumhsse of Equipment | 57 | 57 | 'ID7 | |||||
| Refurbishment costs |
1 | 14 | 15 | 22 | ||||
| Staff Education and Welfare |
20 | 77 | 97 | 70 | ||||
| Patient Welfare | 16 | 25 | 41 | 41 | ||||
| Governance Costs |
10 | 23 | 18 | 41 | 37 | |||
| Total expenditure | 120 | 258 | 378 | 336 | ||||
| Net (loss)/gain an Investments |
13.1~31 | ~24 | ~55 | 118 | ||||
| Net income/(expenditure) | before transfers | 341 | (71) | 270 | 571 | |||
| Transfers between funds |
16 | (95) | 95 | |||||
| Net movement in funds |
18 | 246 | 24 | 270 | 571 | |||
| Fund balances brought farwsrd at 1 April | 1,392 | 1,225 | 2,617 | 2,046 | ||||
| Fund balances carried forward at 31 March | 'I,838 | 1,249 | 2,887 | 2,617 |
| Balance Sheet as at | 31 March 2023 | |||||
|---|---|---|---|---|---|---|
| Note | Unrestricted | Restricted | Total at 31 | Tata Iat31 | ||
| Funds | Funtie | March 2023 | March 2022 | |||
| f000 | f000 | EOOO | f000 | |||
| Fixed Assets | ||||||
| Investments | 13 | 695 | 719 | 1414 | 1469 | |
| Total fixed assets | 695 | 719 | 1,414 | 1,469 | ||
| Current Assets | ||||||
| Stocks | ||||||
| Debtors and accrued income | 14 | 11 | 11 | 12 | ||
| Cash and cash equivalents | 966 | 009 | 1 555 | 1 241 | ||
| Total current assets | 966 | 600 | 1,5 | 1,209 | ||
| Current gabilitles | ||||||
| Creditors: amounts | falling due | |||||
| within one year | 15 | 23 | 70 | 93 | 111 | |
| Net current assets | 943 | 530 | 1,473 | 1,148 | ||
| Total assets lass current liabgitles | 1.638 | 1.249 | 2,887 | 2,617 | ||
| Net Assets | 1,638 | 1,249 | 2,887 | 2,617 | ||
| The funds ofthe Charity | ||||||
| Restricted Income funds | 1,249 | 1,249 | 1,225 | |||
| Unrestricted income |
funds | 1,638 | 'i,638 | 1,392 | ||
| Total Charity Funds | 19 | 1,638 | 1,249 | 2,887 | 2,617 |
| Note | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2022I23 | 2021/22 | |||||||
| 6000 | 6000 | |||||||
| Cash tlows from operating | activitiles: | |||||||
| Net cash from operating | activities | 18 | 267 | 686 | ||||
| Cash flows from investing | activities: | |||||||
| Dividends | and Interest from | Investmenls | 13.3 | 41 | 41 | |||
| Proceeds | from sale ofinvestments | |||||||
| Net cash | provided by investing activities |
41 | 41 | |||||
| Change | in cash and cash | equivalents | In the reporting | period | 308 | |||
| Increase | in cash and cash | equivalents | in the year | 308 | 727 | |||
| Cash and | cash equivalents | at ihe bsg!nnlng of | ||||||
| repcrling | period | 1,247 | 520 | |||||
| Total cash and cash equivalents st the end |
1,555 | 1,247 | ||||||
| ofthe year |
| 3.Voluntar | y Income |
|||||
|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Total | |||
| Funds | Funds | 2022/23 | 2021/22 | |||
| EOOD | EOOD | EOOD | EOOD | |||
| Donations | 2 | 97 | 99 | 91 | ||
| Fundrsising | Income Generated | by Individuals | 16 | 1'I | 27 | 14 |
| Grants Receivable | 97 | 97 | 27 | |||
| Corporate | Donations | 338 | 338 | 362 | ||
| Gift Aid | 5 | 7 | 4 | |||
| Legacies | 161 | |||||
| Total | 458 | 110 | 568 | 659 |
| The income | was primarily from the provis |
ion oftraining courses in |
furtherance ofthe |
Charity's objective | s. |
|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Total | ||
| Funds | Funds | 2D22/23 | 2021/22 | ||
| EOOO | EOOO | EOOD | EOOD | ||
| Income from | the provision | ||||
| ofeducation | and training | 31 | 31 | 41 | |
| Total | 31 | 31 | 41 | ||
| 5.Other Trading Activities | |||||
| Unrestricted | Restricted | Total | Total | ||
| Funds | Funds | 2022/23 | 2D21/22 | ||
| EOOO | FOOD | EDOO | EOOD | ||
| Staff Lottery | deductions | 43 | 43 | 40 | |
| Fundraising | Events | 5 | 3 | ||
| Total | |||||
| 6. Other Incoming Resources | |||||
| Unrestricted | Restricted | Total | Total | ||
| Funds | Funds | 2022/23 | 2D21/22 | ||
| EOOD | EOOD | EOOD | EOOD | ||
| Other Income | 6 | 9 | 15 | 5 | |
| Total | 9 | 15 | 5 |
| 7.Raising F | unds | ||||
|---|---|---|---|---|---|
| 2022/23 | 2021/22 | ||||
| ROOD | ROOD | ||||
| Staff Lottery | Winnings | &Admin | 30 | 28 | |
| Fundraising | Expenses | 'I8 | 5 | ||
| Fundraising | Salary Costs | 42 | 22 | ||
| Total | 55 | 55 | |||
| 8.Charitable | activities | ||||
| The Charity pursued its |
charitable | activities | by making grants. shown below by category. | ||
| 2022/23 | 2021/22 | ||||
| EDDO | EOOD | ||||
| Purchase of | Equipment | 57 | 107 | ||
| Research Posts and Clinical Care | 37 | 4 | |||
| Refurbishment | Costs & | ITEquipment | 15 | 22 | |
| Staff Education and Welfare |
97 | 70 | |||
| Patients Welfare | 41 | 41 | |||
| Total |
| 10.Gov | ernance Costs |
||
|---|---|---|---|
| 2022/23 | 2021/22 | ||
| ROOD | ROD 0 | ||
| Internal | audit | 3 | 3 |
| External | audit | 9 | 6 |
| Governance | 12 | ||
| Financial | administration | 29 | 28 |
| Total | 41 | 37 |
| The investment is valued at bid price 2022/23 and |
The investment is valued at bid price 2022/23 and |
The investment is valued at bid price 2022/23 and |
2021/22 | |
|---|---|---|---|---|
| 13.1 Movement In fixed asset investment |
2022/23 | 2021/22 | ||
| Total | Total | |||
| 6000 | 6000 | |||
| Market value brought | forward | 1,469 | 1,351 | |
| IVionies owed by COLA for | Charities | 10 | 10 | |
| Shorl term dividends | (10) | ('I0) | ||
| Less disposals at carrying Net gain on revaluation |
value | ~55 | 118 | |
| Market value at 31 March | 1,414 | 1,469 | ||
| 13.2 Market value at | 31 March | 2022/23 | 2021/22 | |
| Total | Total | |||
| 8000 | 6000 | |||
| Held in UK | ||||
| COIF Charities Investment |
Fund | 1,414 | 1,469 | |
| Total | 1,414 | 1,469 |
| 2022/23 | 2021/22 | ||||
|---|---|---|---|---|---|
| Asset alfocation | |||||
| Overseas Equities |
63.41% | 64 13% | |||
| Infrastructure | &Operating | Assets | 8.32'Yo | 9.06%o | |
| UK Equities | 8.04% | 8.50% | |||
| Fixed Interest | 7.84% | ||||
| Cash &near | cash | 4 76% | 8.52% | ||
| Property | 3.10% | 458% | |||
| Contractual | &Other Income | 1 85% | 2.76% | ||
| Private Equity | &Other | 2.66% | 2.45o7o | ||
| Oerivatives | O.D2% | ||||
| 100% | 100% |
| 13.3 Total gross income from invest | ments and cash on deposit |
|
|---|---|---|
| 2022/23 | 2021/22 | |
| Total | Total | |
| ROOD | ROOD | |
| Meld in UK | ||
| Investments | 41 | 41 |
| Total | 41 | 41 |
| 14.Deb | tors: amounts | faglng du | e within | one year | |||
|---|---|---|---|---|---|---|---|
| 2022/23 | 2021/22 | ||||||
| Total | Total | ||||||
| RDOO | 6000 | ||||||
| Dividend | Income | 11 | 11 | ||||
| Pre payments | 1 | ||||||
| Accrued | Income | ||||||
| Total | 12 | ||||||
| 15.Creditors: amounts | falling due within | one year | |||||
| 2022/23 | 2021/22 | ||||||
| Total | Total | ||||||
| ROOD | ROOD | ||||||
| Accruals | 31 | 51 | |||||
| Deferred | Income | 2 | 4 | ||||
| Amounts | owed to North | Tees and | Hartlepool | NHS and | |||
| Trading | Companies | 60 | 48 | ||||
| Foundation Trust |
|||||||
| Other creditors | |||||||
| Total | 93 | ||||||
| There is | no security for non-trading | amounts | owed to the | Foundation | Trust. | ||
| 16. Transfers between | funds | 2022/23 | 2021/22 | ||||
| Total | Total | ||||||
| f000 | ROOD | ||||||
| Transfers | 95 |
| 2022/23 | 2021/22 | ||||
|---|---|---|---|---|---|
| Total | Total | ||||
| 6000 | 6000 | ||||
| Net movement in funds |
270 | 571 | |||
| Loss/(Gain) on investments |
55 | (118) | |||
| Deduct interest/dividends | income shown | ||||
| in investing activiTies |
(41) | (41) | |||
| Decrease in debtors | 1 | 268 | |||
| (Decrease)/Increase | in creditors | (18) | 6 | ||
| Net cash generated | from | operating | activities | 267 | 686 |